MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,081,542 | -36.0% | 139,613 | -46.9% | 0.01% | -40.0% |
| Q2 2023 | $9,499,950 | +4.0% | 262,938 | +7.1% | 0.01% | 0.0% |
| Q1 2023 | $9,130,888 | -5.5% | 245,586 | +15.1% | 0.01% | -9.1% |
| Q4 2022 | $9,664,668 | -75.6% | 213,301 | -62.3% | 0.01% | -76.6% |
| Q3 2022 | $39,559,000 | +85.9% | 566,430 | +78.7% | 0.05% | +88.0% |
| Q2 2022 | $21,274,000 | +103.4% | 316,908 | +344.4% | 0.02% | +212.5% |
| Q4 2021 | $10,461,000 | -35.5% | 71,316 | -22.2% | 0.01% | -46.7% |
| Q3 2021 | $16,224,000 | -53.7% | 91,708 | -57.7% | 0.02% | -50.0% |
| Q2 2021 | $35,061,000 | +12.9% | 217,047 | +19.7% | 0.03% | 0.0% |
| Q1 2021 | $31,060,000 | -26.7% | 181,322 | -6.0% | 0.03% | -21.1% |
| Q4 2020 | $42,360,000 | +123.3% | 192,862 | +68.8% | 0.04% | +100.0% |
| Q3 2020 | $18,973,000 | +176.1% | 114,265 | +89.8% | 0.02% | +137.5% |
| Q2 2020 | $6,873,000 | +78.1% | 60,200 | +19.9% | 0.01% | +33.3% |
| Q1 2020 | $3,859,000 | -25.5% | 50,200 | +24.9% | 0.01% | +20.0% |
| Q4 2019 | $5,181,000 | +551.7% | 40,200 | +294.1% | 0.01% | +400.0% |
| Q3 2019 | $795,000 | -22.8% | 10,200 | +2.0% | 0.00% | 0.0% |
| Q2 2019 | $1,030,000 | +273.2% | 10,000 | +165.7% | 0.00% | – |
| Q1 2019 | $276,000 | -89.4% | 3,763 | -93.9% | 0.00% | -100.0% |
| Q4 2018 | $2,597,000 | -7.7% | 61,225 | +2.5% | 0.00% | +33.3% |
| Q3 2018 | $2,814,000 | -72.2% | 59,745 | -70.9% | 0.00% | -76.9% |
| Q2 2018 | $10,124,000 | +16.1% | 205,346 | -27.7% | 0.01% | +8.3% |
| Q1 2018 | $8,722,000 | -0.1% | 284,091 | -40.6% | 0.01% | 0.0% |
| Q4 2017 | $8,732,000 | +29.3% | 478,483 | -17.1% | 0.01% | +20.0% |
| Q3 2017 | $6,752,000 | +2181.1% | 577,082 | +611.0% | 0.01% | – |
| Q2 2017 | $296,000 | +19.8% | 81,167 | +70.8% | 0.00% | – |
| Q1 2017 | $247,000 | +3.8% | 47,514 | -5.2% | 0.00% | – |
| Q4 2016 | $238,000 | +226.0% | 50,115 | +356.5% | 0.00% | – |
| Q3 2016 | $73,000 | -80.1% | 10,977 | +3.1% | 0.00% | -100.0% |
| Q3 2015 | $367,000 | – | 10,650 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |